Pharmaceutical Innovation
Revolutionizing Human Health (review)
Bibliographic Data
| ID | 14528468 |
|---|---|
| Authors | Judy Slinn (corresponding author) |
| Year | 2001 |
| Volume | 42 |
| Issue | 1 |
| Pages | 202-203 |
| Publication date | 2001-01-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Technology and Culture (JOURNAL) |
| Journal identifiers | ISSN: 0040-165X • E-ISSN: 1097-3729 |
| Publisher | Project MUSE (PUBLISHER • US) |
| DOI | 10.1353/tech.2001.0038 |
| OpenAlex | W1997855347 |
| Language | EN |
This book sets out to explore the historical evolution of the pharmaceutical industry over the last 150 years, identifying the major discoveries and evaluating them in terms of their scientific novelty, their economic value, and their significance for human health. Its main focus is on the second half of the twentieth century, when the pace of innovation in the industry has been most rapid. In that time frame the large U.S. corporations--based in the world's largest pharmaceutical market, and in the last two decades increasingly global in character--have dominated the industry and enjoyed a national innovative advantage, so inevitably they claim the most attention
Biology · Business · Drug industry · Engineering ethics · Frame (networking) · Geography · Human health · Industrial organization · Novelty · Pace · Pharmaceutical industry · Value (mathematics) · Biotechnology · Computer Science · Engineering · Health and Medical Research Impacts · Marketing · Medicine · Pharmaceutical industry and healthcare · Science, Research, and Medicine
| Highly cited | No |
|---|